Appendix Table 5D.
Event study for prescription medications financed by Medicaid: SDUD 2010-2015
| Outcome: | Prescriptions per 100,000 non-elderly adults |
|---|---|
| Pre-expansion mean in the expansion state group | 806 |
| Treat *2011 Q1 | 23.260 (98.965) |
| Treat *2011 Q2 | 57.486 (111.705) |
| Treat *2011 Q3 | 13.170 (109.795) |
| Treat *2011 Q4 | 24.571 (97.958) |
| Treat *2012 Q1 | −36.105 (62.803) |
| Treat *2012 Q2 | −14.334 (69.293) |
| Treat *2012 Q3 | −16.088 (75.358) |
| Treat *2012 Q4 | 8.701 (72.854) |
| Treat *2013 Q1 | 41.583 (40.678) |
| Treat *2013 Q2 | 76.230 (48.118) |
| Treat *2013 Q3 | 14.219 (22.267) |
| Treat *2014 Q1 | 156.076* (80.437) |
| Treat *2014 Q2 | 306.145* (152.557) |
| Treat *2014 Q3 | 499.113*** (165.335) |
| Treat *2014 Q4 | 393.790*** (111.150) |
| Treat *2015 Q1 | 438.059*** (128.960) |
| Treat *2015 Q2 | 638.525*** (175.015) |
| Treat *2015 Q3 | 618.154*** (164.769) |
| Treat *2015 Q4 | 761.336*** (193.799) |
| F-test of joint significance of policy leads (p-value) | 0.2834 |
| N | 896 |
Notes: All models estimated with OLS and control for state demographics, state fixed effects, and period fixed effects. Standard errors are clustered at the state level and are reported in parentheses. The omitted period is 2013 Q4. Early expanding states excluded from the sample.
***;**;*
=statistically different from zero at the 1%;5%;10% level.